Download PDF
Thromb Haemost 1984; 51(02): 291
DOI: 10.1055/s-0038-1661079
Letter to the Editor
Schattauer GmbH Stuttgart

Circulating Anticoagulant against Factor XII and Thrombocytopenic Purpura

J M Vilà
The Hematology Service, Hospital de Girona, Girona, Spain
,
J Juncà
The Hematology Service, Hospital de Girona, Girona, Spain
,
J Profitòs
The Hematology Service, Hospital de Girona, Girona, Spain
,
S Maragall
1   The Blood Bank and Haemostasis Service, Hospital Clinic, Barcelona, Spain
› Author Affiliations
Further Information

Publication History

Received 05 September 1983

Accepted 24 November 1983

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Aberg H, Nilsson IM. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against Factors XI and XII. Acta Med Scand 1972; 192: 419-425
    PubMedSearch in Google Scholar
  • 2 Gandolfo GM, Afeltra A, Amoroso A, Biancolella F, Ferri GM. Circulating anticoagulant against Factor XII and platelet antibodies in Systemic Lupus Erythematosus. Acta Hematol 1977; 57: 135-142
    CrossrefPubMedSearch in Google Scholar
  • 3 Bateman d, Gokal R, Prescott R, Hamilton PS, Kerr DN S. Minimal change glomerulonephritis associated with circulating anticoagulant to Factor XII. Br Med J 1980; 2: 358
    PubMedSearch in Google Scholar
  • 4 Duran JR, Vila M, Rodriguez BuenoS, Triginer J. Circulating anticoagulant against Factor XII in smoldering leukemia. Acta Haematol 1982; 67: 128-131
    CrossrefPubMedSearch in Google Scholar
  • 5 Valentin IR, Rimon A, Lahav M. Inhibition of blood coagulation Factor XI und XII by monoclonal IgM (abstract). Israel J Med Sci 1975; 11: 1392
    PubMedSearch in Google Scholar
  • 6 Cronberg S, Nilsson IM. Circulating anticoagulant against Factors XI and XII together with massive spontaneous platelet aggregation. Scand J Hematol 1973; 10: 309-314
    PubMedSearch in Google Scholar
  • 7 Rolović Z, Elezović I, Obranović B, Rizza C. Life threatening bleeding due to an acquired inhibitor to Factor XII-XI successfully treated with „activated“ prothrombin complex concentrate (FEIBA). Br J Haematol 1982; 51: 659
    PubMedSearch in Google Scholar
  • 8 Odgston D, Bennet B. (eds) Haemostasis. 1. A Wiley Interscience Publication; London: 1977. p 487
    Search in Google Scholar
  • 9 Caen J, Larrieu MJ, Samama M. La Hemostasia. 1a . Toray Masson SA. Barcelona: 1977. p 170
    Search in Google Scholar